It was recently reported that while plasma levels of Syndecan-1 (along with other GAGs/PGs) increased in monocrotaline (MCT)-induced PAH rats, they decreased in the pulmonary arteries compared to wild-type controls [217], suggesting destruction of the pulmonary vascular glycocalyx. The gene discussed is SDC1; the disease is pulmonary arterial hypertension.